ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,917.11
0.00%
US Tech 100
20,176.00
0.24%
Dow Jones
43,408.47
0.32%
Brent Oil
74.055
1.67%
Bitcoin
97,826.46
3.69%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oncology Institute Inc (TOI)

  7. Oncology Institute Inc (TOI) News

Oncology Institute Inc

Oncology Institute Inc (TOI)

Topicus Com Inc
0.1322
-0.0478
(-26.56%)
Closed November 20 4:00PM
Delayed by 15 minutes
0.136
0.0038
( 2.87% )
Pre Market: 7:15AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

TOI News

Official News Only

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
January 19 2024
TOI (-26.56%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 28 2023
TOI (-26.56%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 28 2023
TOI (-26.56%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 28 2023
TOI (-26.56%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 04 2023
TOI (-26.56%)

TOI Discussion

View Posts
glenn1919 glenn1919 2 days ago
TOI..........................https://stockcharts.com/h-sc/ui?s=TOI&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 3 months ago
TOI
New 52 week low
👍️0
boston127 boston127 12 months ago
Thanks. I like it.

I may approach them about reselling my company's product.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
MREO MY FAV BIO
👍️0
boston127 boston127 1 year ago
I did. Where do you recommend next?

Is this going to be a better play soon? I am in heavy, and in the red, with LGHL. would appreciate a quick look and feedback on that board, not here. TOI has so many good things going for it - owned by institutions - it is going to be hard for me not to eventually get in here.
👍️0
boywonder1 boywonder1 1 year ago
The chart has contradictions like yourself and you're posting history ‼️‼️2😂
👍️ 1 💯 1
TrendTrade2016 TrendTrade2016 1 year ago
Glad you listened
👍️0
boston127 boston127 1 year ago
You were correct. Took a major haircut.

Glad I did not jump in. Thanks. What do you like?
👍️0
boston127 boston127 1 year ago
The Warrants do not expire

until November, 2026. I may start adding them. I can get 10 Ws for every 1 Common.
👍️0
boston127 boston127 1 year ago
What important indicators?

TOI appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
As of 3:00 PM ET Friday, 11/03/2023
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
important indicators going down as stock is going up...red flag!!!!
👍️0
boston127 boston127 1 year ago
Can you explain?

Do you know anything about the warrants? Strike price, expiration date, etc.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
CHART HAS SOME CONTRADICTIONS
👍️0
boston127 boston127 1 year ago
It sure is acting perky.

Nice move AH and Premarket. I'm going to jump in today if the move north continues.
👍️0
boston127 boston127 1 year ago
Common goes down.

Warrants go up on very light volume. Hard to figure.
👍️0
hedge_fun hedge_fun 1 year ago
She was under 40 cents in mid June……

I would say she’s is already flying.

Been my best play this year.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TOI...READY TO FLY
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TOI...READY TO FLY
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
MONSTER IN DA MAKING
👍️0
hedge_fun hedge_fun 1 year ago
It’s tripled since mid-June…..
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
MONSTER PLAY HERE....
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TOI BEAUTY BOTTOM HERE ...AI CANCER PLAY
👍️0
hedge_fun hedge_fun 1 year ago
Company repurchasing more shares. Nice…..
👍️0
hedge_fun hedge_fun 1 year ago
August starting out like July…….
👍️0
hedge_fun hedge_fun 1 year ago
On watch. Thx
👍️0
CaptPete1776 CaptPete1776 1 year ago
Keep eye in $Getr over .55. That’s the breakout spot could explode over .70. I’ve been swinging this also.
👍️0
CaptPete1776 CaptPete1776 1 year ago
I have some left yes just don’t want to get to greedy
👍️0
hedge_fun hedge_fun 1 year ago
I hope you’re still holding some. I’m enjoying the ride.
👍️0
CaptPete1776 CaptPete1776 1 year ago
Looks great. I sold some here .89
👍️0
hedge_fun hedge_fun 1 year ago
I don’t want July to end!!!
👍️0
CaptPete1776 CaptPete1776 1 year ago
Holding in today's nasdaq slide and up on the day. .90 is coming next
👍️0
CaptPete1776 CaptPete1776 1 year ago
Yes definitely
👍️0
hedge_fun hedge_fun 1 year ago
Been a nice move the past 2 weeks……
👍️0
hedge_fun hedge_fun 1 year ago
The low volume dips with 100 share trades……

are fishy.

Maybe this proves to be support.

Long term hold for me.
👍️0
CaptPete1776 CaptPete1776 1 year ago
Let’s get more good new out. It’s been holding strong since the last news about stock repurchase plan.
👍️0
hedge_fun hedge_fun 1 year ago
On June 14, 2023, the Board of Directors of The Oncology Institute, Inc. (the “Company”) approved a share repurchase program with authorization to purchase up to 5 million shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The Company may repurchase shares from time to time through one or more securities broker-dealers, in open market purchases and negotiated purchases, in each case at price per share not to exceed $0.75. Shares repurchased by the Company pursuant to the share repurchase program shall be returned to the status of authorized but unissued shares of Common Stock.

In connection with the foregoing, on June 14, 2023, the Company entered into a limited consent (the “Limited Consent”), dated as of June 14, 2023, to that certain Facility Agreement, dated as of August 9, 2022 (the “Facility Agreement”), by and among the Company, as borrower, certain of the Company’s subsidiaries from time to time party thereto as guarantors and Deerfield Partners, L.P., as agent for itself and the lenders (collectively, “Deerfield”). The Limited Consent permits the repurchase by the Company on or prior to June 16, 2023, of up to 5,000,000 shares of the Company’s Common Stock in one or more open market or negotiated purchases, in each case at price per share not to exceed $0.75. The actual timing and amount of repurchases are subject to business and market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors. The Limited Consent does not obligate the Company to repurchase any amount of shares, and there can be no assurance that any shares will be repurchased. The Limited Consent also grants a one-time waiver under the Facility Agreement of certain delivery of any notice requirements.

The foregoing description of the Limited Consent does not purport to be complete and is qualified in its entirety by reference to the full text of the Limited Consent, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
👍️0

Your Recent History

NASDAQ
TOI
Oncology Institute
BOV
PETR4
PETROBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved